… Although chemotherapeutic advances have recently been heralded in lung adenocarcinomas,
such success with small-cell lung cancer (SCLC) has been ominously absent. Indeed, the …

… cancer has expanded significantly, particularly in the last few years with the proven benefit
… chemotherapy. For advanced stage non-small cell lung cancer (NSCLC), chemotherapy …

… -line treatment of small-cell lung cancer: A phase II study in patients with refractory and
sensitive disease. The European Organization for Research and Treatment of Cancer Early …

… Treatment of small cell lung cancer. diagnosis and management of … Role of radiation therapy
in the combined-modality treatment of patients with extensive disease small-cell lung cancer…

… , a combination of chemotherapy with chest radiotherapy is … is short and they are not
curative in most instances, with 5-year survival rates less than 7%. No major treatment advances …

… in short-term survival since the introduction of chemotherapy in the … in lung cancer has
focused on non-small-cell lung cancer (NSCLC). There have however been some developments …

… Topotecan in the treatment of recurrent small cell lung cancer: … Topotecan in the treatment of
recurrent small cell lung cancer… Topotecan in the first-line treatment of small cell lung cancer. …

… 2 Photomicrograph of a representative small cell lung carcinoma from a cytologic specimen
after … Chemotherapy for relapsed small cell lung cancer: a systematic review and practice …

… later in patients with at least SD following first line chemotherapy (NCT03319940) is in
progress. AMG119 is an adoptive cellular immunotherapy, consisting of patients’ derived CAR T …

… lead efforts to facilitate progress in this particular … Small Cell Lung Cancer (59), an international
initiative created by the National Cancer Institute (NCI) based on the Recalcitrant Cancer …